Being p21 and p16INK4A markers associated with good prognosis in different cancers, such as adenocarcinoma and Hodgkin lymphoma, these results suggest that patients with CCA who have a high expression of these markers might be predicted as belonging to a good prognostic group [165]. This evidence concerns the gene CDKN1A and cholangiocarcinoma.